January 06, 2026

Tomorrow’s Science Leaders Roundtable: Part Two

Isabelle Kohler, Charlotta Turner, and Lourdes Ramos discuss AI, success, and redefining impact in an age of change

The Analytical Scientist

December 30, 2025

Mendelian Randomization: A Powerful Tool — When Used Properly

New TVST editorial examines the promises and Pitfalls of MR in ophthalmology

The Ophthalmologist

December 19, 2025

Post cataract surgery endophthalmitis in the intracameral antibiotic era: What else can we do in 2025?

Learning objectives for this Grand Rounds course include identifying and decreasing the relative risk of postoperative endophthalmitis in potentially higher risk patient groups.

Mayo Clinic

December 19, 2025

Dear ADA: Annual maximums

Many dental plans’ annual maximums have not increased in 50 years.

ADA News

December 19, 2025

Integrating Mental Health Into Cancer Care: A Community Oncology Imperative

When Julie began chemotherapy for breast cancer, her oncologist adjusted antiemetics weekly and carefully tracked neutrophil counts. Still, no one asked about the panic attacks that kept her awake at ...

The ASCO Post

December 17, 2025

Bridging the Digital Divide: How Collaboration and Standardization Are Shaping the Future of Biotech

The promise of cell and gene therapy is boundless, but data silos are holding it back. Standardization, interoperability, and collaboration can move data as freely as science itself.

The Medicine Maker

December 15, 2025

ADA to conduct governance and organizational health study in 2026

The ADA has issued a request for proposals to select a consultant to conduct the evaluation.

ADA News

December 15, 2025

Artificial Intelligence in Health Care: The Ethical Frontier

At AMP 2025, Takunda Matose, PhD, urged pathologists to consider the limitations of big data and probabilistic reasoning to maximize AI’s benefits for clinical outcomes.

The Pathologist

December 15, 2025

Lighting the Way Forward for Metabolomics

Advanced software tools and self-correcting instruments could soon put the dark metabolome debate to bed, argue Alexander Makarov and the Thermo Fisher Scientific team

The Analytical Scientist